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Foamy vinlses belong to the retrovinases wbich possess a complex genome stmc,ture: Tbe human foamy vi~s 
(HFV) isolate bears three open reading frames (the so-called be_l ge~es) in tbe ~ regJ?~ of the genome ~eh 
have been reported to give rise to possibly six difl'erent proteans Vl8 alternative splicmg (W. ~uranya and 
R. M. Flügel, J. VII'OI. 65:727-735, 1991). In order to analyze the requirements of these pro.teans for HFV 
replication in vitro, we constnJ.cted a set of single and combinatory bel gene mutaots of an infecüous mol~ar 
clone of mv. Tbe mutant which lacked the transacting ac~vator, bel-l, was. found .to RK: replic:ataon 
incompetent. AU other mutants repUcated equally weU and gave nse to comparable üters .of m~ectious ceD·free 
vinas. Wben mv provinases were put under the control of a heterologous promoter (simaan ~ 40), none of 
the accessory gene products was found to be required for expression o_f structural (gag) protea~s. Tbere was no 
evidence for a posttranscriptional regulatory protein that is present an other complex retroVllUses. 
The foamy viruses are far less weil characterized than 
other subgroups of retroviruses (9). The human foamy virus 
(HFV) isolate of Achong et al. (1) has been molecularly 
cloned and sequenced (10, 22, 31). The presence of acces-
sory reading frames in addition to gag, pol, and env (10), 
evidence of a complex transcription pattem (23), and the 
identification of a virus-encoded transactivator of long ter-
minal repeat (LTR)-directed transcription (16, 32) indicate 
that foamy virus gene regulation is similar to that of lentivi-
ruses and other complex regulated retroviruses (5). 
The accessory reading frames of HFV are located in the 3' 
region of the genome between the env gene and the 3' LTR 
and have been designated bel (Fig. lA) (10). On the basis of 
polymerase chain reaction-mediated mapping of splice sites, 
sixbel gene-derived proteins, namelybel-1, bel-2, bel-3, bes, 
bet and beo, have been postulated (Fig. lB) (23). However, 
deflnite proof for the existence of se~eral of these prot~ins ~s 
lacking, and only the bel-l protem has been stud1ed 10 
greater detail. The bel-l gene has been reported to encode a 
36,000-molecular-weight nuclear phosphopro~ein (36K nu-
clear phosphoprotein) that acts as a transactlvator of tran-
scription on distinct U3 elem~nts of ~he viral L TR (8, 16, ~· 
32, 38). By using a bel-2-specdic ant1serum, several prote~s 
have been identified in infected cells (21). The most proma-
nent of the bel-2 reactive proteins (bet) was also stained with 
bel-l antiserum (21), consistent with RNA mapping (23) and 
cDNA cloning data (14) that revealed a splice from the bel-l 
open reading frame (ORF) into the bel-2 ORF (Fig. lB). 
It has been demonstrated previously that the bel-l 
genomic region is required for HFV replication (21). How-
ever, that study did not show the effect of singl~ gene 
mutations but did show the Iethai effect of a combmatory 
bel-l, bet, beo, and bel-3 mutant on viral replication. Since 
only the bel-l protein has been assigned a function, we 
aimed to investigate the relevance of the accessory ~ 
reading frames for the viral replication cycle by analyzmg 
single bel gene mutants of an infectious molecular HFV 
clone. 
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MATERIALS AND METHODS 
Piasmid constnJ.ctions. All plasmid constructions were 
done by established recombinant DNA. tc:chniques (33): All 
constructs were characterized by restnctaon enzyme diges-
tion and/or dideoxy sequencing (34). 
mv mutants. Mutants of the infectious molecular clone 
pHSRV (30) are shown in Fig. lC. For construction of Ml, 
an Xbal linker (New England Biolabs) providing a stop 
codon in the bel-l reading framewas inserted into the Stul 
site in the bel-l gene of pEB3L (30). The 5' part of the 
genome was introduced into the modified pEB3L plasmid as 
a Kpnl-Aatll fragment derived from p5LGPE as described 
previously (30). M2 and M3 were derived from p4gpe88 and 
p4gpeH (32) by exchanging the 5,396-bp .Kpnl-Aatll frag-
ments of these constructs with the respective 9,317-bp 
fragment of p5LGPE. For the mutation of overlapping 
reading frames in M4 to M9, BamHI-Hindlll and EcoRl-
Xbal fragments of pEB3L were introduced into the 
ml3mpl9 vector, and site-directed mu~agenesis was carri<:d 
out as descnöed previously (35) by usmg the Amersham m 
vitro mutagenesis system. Mutated fragmen~s from the m~3 
vector were then substituted for the respective fragments m 
pHSRV. M4 was generated by using the oligonucleotide 
5'-GAGACGATCCATAGATAATGAGTC-3' (the mutated 
nucleotide is underlined); for construction of MS~ the oligo-
nucleotide 5'-AGGGCrACfAGAAGAGTCCAG-3' was 
used· for generation of M7, the oligonucleotide 5' -CATGGT 
TAcl:AA.GCAGCfAT-3' was used; and the oligonucleotide 
5'-CCI'AGGATAGGAGAAGGACAT-3' was used to con-
struct M8. M6 combines the mutations of M4 and MS, and 
M9 combines the mutations of M6 and M8. 
HFV mutants witb simian viru.s 40 (SV40) promoter. Start-
ing from pSV2cat (11), the Hindill and Ndel sites 'Yere 
converted by linker insertion into Sacl and Kpnl s1tes, 
respectively. A 950-bp Sacl fragment ofpHSRV comprising 
R-U5 and somegag sequences was introduced, giving rise to 
pSRU5G. This plasmid was cut with Narl and~atll, and the 
respective 8,146-bp fragment of p5LGPE was mserted, lead-
ing to pSRU5GPE. The Kpni-Aatll fraFent of pSRU?GPE 
was then cloned into pEB3L, generatmg pSHFV -1; mto a 
derivative ofpEB3L lacking a 423-bpAcci-Hindlll fragment 
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FIG. 1. Genome ~rganization (A), transcripts (B), and virus mutants (C) of HFV and constructs witb tbe SV40 promoter (D). For clarity, 
only the protein-coding exons in tbe bel genomic region as deduced from reference 23 are shown in panel B. Tbe respective mutated open 
reading frames are indicated in panels C and D. Tbe lengths in amino acids of tbe bel·gene-derived proteins truncated by in vitro mutagenesis 
(small verticallines) are shown in parentbeses in panel C. A,Accl; B, BamHI; Bg, Bgßl; H, Hindlll; S, Stul; SV, SV40 enhancer-promoter. 
that comprises bel-2 and bel-3 sequences (to be described in 
detail elsewhere), resulting in pSHFV-2; and into pEB3L 
bearing the Stul mutation in the bel-l gene of M1, generating 
pSHFV -4. pSHFV -3 was derived from pSHFV -1 by deleting 
a 208-bp BamHI fragment comprising bel-l and bel-2 se-
quences. The pSHFV plasmids are shown in Fig. 10. 
CeUs and viruses. Baby hamster kidney cells (BHK-21), 
human glioblastoma cells U-251 MG, and primary human 
embryonie lung fibroblasts (HEL) were obtained from D. 
Neumann-Haefelin (Freiburg, Germany), D. Bigner (Dur-
harn, North Carolina), and F. Hanns (Würzburg, Germany), 
respectively. These cells have been shown previously to 
support HFV replication (30). Cells were maintained in 
minimal essential medium supplemented with 5% fetal calf 
serum, glutamine, and antibiotics. Virus derived from cal-
cium phosphate transfection (12) of molecular clones was 
grown on BHK cells. Stock virus was prepared from cell-
free culture supernatant (0.22-J.Lm-pore-size filtrate ), ali-
quoted, and stored at -70°C until use. 
Reverse transcriptase assay. BHK cells transfected with 5 
J.L8 of pHSRV or mutant plasmid DNA were harvested by 
scraping, washed with phosphate-buffered saline (PBS), 
resuspended in TNE (100 mM Tris-HCl [pH 7.4], 10 mM 
NaCl, 1 mM EDTA) containing 0.1% Nonidet P-40, sub-
jected to five cycles of freezing and thawing in dry ice-
ethanol and 37°C baths, and finally centrifuged for 1 min at 
10,000 x g. Protein (25 J.Lg), as determined with a commer-
cial protein assay (Bio-Rad), was assayed in 100-J.Ll reaction 
mixture volumes containing 50 mM Tris-HCl (pH 7.5), 40 
mM KCI, 1 mM MnC12 , 0.1% Nonidet P-40, 1 mM dithio-
threitol, 100 J.L8 of bovine serum albumin (BSA), 10 J.LM 
dTTP, 0.1 mg of (rA)n(dThS-18 (Boehringer-Mannheim) per 
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ml, and 5 J.LCi of (3H]dTIP (Amersham) for 60 min at 37"C. 
The radioactivity of the acid-insoluble fraction was deter-
mined by scintillation spectroscopy. 
Vinas titration. BHK cells were seeded at a density of 2 X 
l<f to 3 x 10" cells per weil into 12-well plates. After 6 h for 
attachment of cells, 1 ml of virus suspension was added. The 
virus suspension was diluted 10-fold in culture medium from 
w-2 to w-7, and 10 wells per dilution were analyzed. The 
medium was changed after 16 h, and the cells were cultivated 
for a further 48 h prior to fixing in cold methanol. For 
immunodetection of viral gag antigen, plates were incubated 
with rabbit g~g2 antibody, directed against the major capsid 
protein p328'as (2) and diluted 1:100 in PBS containing 0.1% 
bovine serum albumin (BSA) for 45 min at 37°C. After the 
plates were washed with PBS-BSA, peroxidase-coupled goat 
anti-rabbit antibody (Dako) was added, and the incubation 
was continued for 45 min at 37°C. The cells were washed, 
and the immunostain was developed with 200 J.Lg of 3-amino-
9-ethylcarbazole (Sigma) per ml in 50 mM sodium acetate 
(pH 5.0)-0.5 J.Ll of H20 2 per ml. Positive wells were counted 
under a light microscope. Virus titers were calculated as 
described previously (29). 
CAT assay. The HFV eflector plasmid (10 J.Lg) and p5'cat 
(-777 to +351) indicator plasmid (5 J.Lg) (32) were trans-
fected into 5 x lOS BHK cells as described previously (12). 
The DNA concentration in the transfection mixwas adjusted 
to 40 J.Lg/ml with herring sperm DNA. After 36 h, cells were 
harvested, and chloramphenicol acetyltransferase (CAT) 
assays were performed as described previously (32) with 50 
J.Lg of protein from each transfection. Quantification of the 
acetylated and nonacetylated chloramphenicol on the chro-
matography plates was done in three independent assays 
with a Molecular Dynamics Phosphorlmager. 
Western blot and indirect immunofluorescence. The gener-
ation of the antisera directed against HFV gag and bel-l has 
been described recently (2). The bel-2 antiserum was gener-
ated similarly by immunization of rabbits with a prokaryot-
ically expressed bel-2 antigen. For antigen preparation, a 
carboxy-terminal 450-bp Hindill fragment of bel-2 was in-
serted into the bacterial overexpression vector pROS (7), 
and the LacZ-bel-2 fusion proteinwas purified as reported 
previously (2). 
Lysates of virus-infected or transfected BHK cells were 
prepared after the cells were washed with PBS and resus-
pended in cold detergent bufler (20 mM Tris-HCl [pH 7.4], 
0.3 M NaCI, 0.1% sodium dodecyl sulfate (SDS], 1% sodium 
desoxycholate, 1% Triton X-100, 1 mM phenylmethylsulfo-
nyl ftuoride ). The protein amount was measured with a 
commercial assay (Sigma). Equal amounts of proteins were 
separated by SDS-10% polyacrylamide gel electrophoresis 
(SDS-PAGE) and semi-dry blotted onto nitrocellulose mem-
brane (Schleicher & Schuell). The membranes were blocked 
ovemight in Tris-buflered saline (20 mM Tris-HCI (pH 7 .6], 
137 mM NaCl) containing 5% BSA (TBS-BSA) and were 
washed briefty in TBS-0.5% Tween 20. Immunodetection 
was performed by incubating the membranes with rabbit 
antisera diluted 1:500 in TBS-BSA for 30 to 60 min. After the 
membranes were washed, peroxidase-conjugated second 
antibody (Dako) was added at a 1:500 dilution in TBS-BSA 
for 60 min. The membranes were washed, and blots were 
developed with the ECL chemiluminescence detection sys-
tem (Amersham). 
An indirect immunoftuorescence assay was performed 
with infected HEL cells grown on coverslips and fixed in 
cold methanol. Slides were incubated with bel-l- or bel-2-
reactive or normal rabbit serum diluted 1:200 in PBS-BSA at 
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37"C for 45 min. After the cells were washed in PBS-BSA, 
incubation was continued with ftuorescein-conjugated sec-
ond antibody (Dako). The coverslips were washed and 
mounted for ftuorescence. 
RESULTS 
Design or vinls mutants. The published transcript pattem 
of HFV suggests a variety of be/-derived proteins (23) (Fig. 
lB). However, there .is no information concerning the pos-
sible functions of these proteins, except for bel-l. We 
therefore constructed a set of mutants (Fig. lC) of the 
infectious molecular clone pHSRV (32) to elucidate func-
tional aspects of the bel proteins. Ml disrupts the bel-l ORF 
by introduction of a stop codon after 106 of 300 codons 
Without destroying any of the other reading frames. In 
particular, the frequently used splice donor and splice ac-
ceptor sites of the viral RNA, nucleotides 8922 and 9224 (23), 
respectively, remain unaflected in this construct. M2 bears 
an 89-bp deletion upstream of a Bgßl site in the bel-2 ORF 
(32) that terminales the putative bel-2 and bet proteins after 
122 and 248 codons of 356 and 482 codons, respectively. M3 
harbors an in-frame 93-bp Hindill deletion of the bel-2 and 
bel-3 ORFs (32), which deletes codons 197 to 228 of bel-2, 
codons 323 to 354 of bet, and the 3' splice acceptor sites for 
the beo and bel-3 mRNAs, assuming that they are generated 
as reported previously (23) (see below). Since there is 
extensive overlapping of reading frames in the bel region 
(Fig. lA), we introduced four mutants into the bel-2 and 
bel-3 ORFs by in vitro mutagenesis, thereby conserving the 
respective overlapping reading frame. M4 creates a stop 
codon in the bel-2 ORF just upstream of the first bel-2 AUG. 
Since the joint splice acceptor site for bel-2 and bet was 
reported to be located 113 nucleotides upstream of the bel-2 
AUG (23), M4 terminales bet alone after 124 codons. M5 
creates a stop downstream of the second bel-2 AUG, termi-
nating bel-2 after 33 codons and bet after 159 codons. M7 is 
a bel-2 ORF mutant that would terminale bel-2 after 222 
codons, bet after 348 codons, and beo, after 109 of 242 
codons. M8 is a bel-3 ORF mutant that terminales bel-3 after 
99 of 210 codons, assuming that bel-3 is expressed from a 
spliced mRNA thatjoins a bel-l exon with the bel-3 ORF as 
reported previously (23). However, regarding the postulated 
· beo and bel-3 proteins, the study of Muranyi and Flügel (23) 
contains an inconsistency, since they reported the transla-
tion of two proteins (beo and bel-3) having identical amino-
terminal sequences but different carboxy-terminal sequences 
from a single mRNA (containing exon 7 and exon 10 (23]). 
We therefore designed M7 and M8 to cover eilher possibility 
in the generation of beo or bel-3. M6 is a double mutant 
combining the mutations of M4 and MS, and M9 is a triple 
mutant of M6 and M8. 
Infectivity assay of virus mutants. The parental and mutant 
plasmids were transfected into BHK cells, and the cells were 
observed for the occurrence oftypical foamy virus giant cell 
cytopathic eflect (26) in addition to the determination of 
cell-associated reverse transcriptase. Cytopathic eflect CPE 
developed in all cultures, except the Ml-transfected cells. 
Furthermore, reverse transcriptase activity was monitared 
in all but the Ml-transfected cultures, indicating active virus 
replication (Table 1). The observation of reverse tran-
scriptase activity, in particular in cultures transfected with 
the mutant M9, indicated that bel-l is the only regulatory 
protein required for HFV in vitro replication. When U-251 
MG and HEL cells were infected with cell-free supematants 
of the reverse transcriptase-positive cultures, subsequently, 
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TABLE 1. lntracellular reverse transcriptase activity and titers of 
cell-free virus obtained with pHSRV and mutant viruses 
Construct RT activity" Titerb (ORF mutated) (1Q4 cpm) 
pHSRV 2.13 4.3 X lOS 
Ml (bel-l) 0.06 NIY 
M2 (bel-2, bet) 1.59 2.9 X lOS 
M3 (bel-2, bet, bel-3, beo) 5.33 1.1 X 106 
M4 (bet) 3.72 2.2 X 106 
M5 (bel-2, bet) 1.62 B.2 X lOS 
M6 (bel-2, bet) 5.77 ND 
M7 (bel-2, bet, beo) 1.26 ND 
MB (bel-3) l.B6 1.6 X lW 
M9 (bel-2, bet, bel-3) 2.74 ND 
a BHK-21 ceUs were transfected with 5 11-8 of plasmid DNA, and the reverse 
transcriptase (RT) activity was determined from cellular lysates on day 5 after 
transfection, as described in Materials and Methods. 
b BHK.-21 ceUs were infected with cell-free virus at a multiplicity of 
infe~tion of 0.1. Threc: days later, ceU-free supematants wcre barvcsted, and 
the titers were determmed on BHK ceUs. Calculation of virus titers was done 
as described previously (29). 
c ND, not done. 
typical foamy virus CPE developed in those cells (see Fig. 3 
and data not shown). 
. To get a better insight in the replication competence of the 
vtrus mutants, we analyzed the titers of cell-free virus under 
defined conditions. Stock viruses were titrated, and BHK 
cells were infected at a multiplicity of infection of 0.1. Three 
days after infection, cell-free supernatants were harvested 
and titers were again determined. As shown in Table 1 th~ 
highest titer obtained was with the bet-minus mutant 'M4. 
However, the differences between titers were less than 
10-~ol~; thus, they were within the range of biological 
vanat10n. 
Transadivation of the HFV LTR by virus mutants. For 
human immunodeficiency virus, it has been reported that the 
vpr and nef gene products influence the gene expression of 
the homologous LTR (3, .4, 27). We therefore investigated 
wheth_er HFV behaves similarly by analyzing the ability of 
the vtrus mutants to augment reporter gene expression 
directed by the complete HFV L TR. As shown in Table 2, 
only minor differences in transactivation of the HFV L TR 
were found between pHSRV and M2 to M9, with M9 · 
TABLE 2. Augmentation of HFV LTR-directed gene expression 
by pHSRV and mutant viruses 
Construct (ORF mutated) 
pHSRV ..........•..............................................•..•..•.. 
Ml (bel-1) .•.•........................................................... 
M2 (bel-2, bet) ........................................................ . 
M3 (bel-2, bet, bel-3, beo) ........•................................ 
M4 (bet) .....•.......................•...........•.•..•.................. 
MS (bel-2, bet) ...................•.......•.....•..........•.......•.... 
M6 (bel-2, bet) .............••................•...•.......••.•.....••... 
M7 (bel-2, bet, beo) ................................................. . 
MB (bel-3) .............................................................. . 
M9 (bel-2, bel-3, bet) ............................................... . 
pUC ........•.•..........................•..................•............. 
Fold 
activationa 
36 
1 
37 
34 
51 
25 
53 
47 
36 
58 
1 
a Effector plasmids and tbe p5'cat (-777 to +351) indicator plasmid were 
cotransfected int_? BHK.-21 cells. CAT activity in the lysates of transfected 
ceUs was determmcd, and the fold activation by a given effector plasmid was 
calculated relative to the value obtained by cotransfecting pUC DNA as a 
mean from three independent experiments. 
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transactivating the HFV LTR slightly better than the paren-
tal construct or any of the other mutants. No transactivation 
was observed for Ml, indicating that the mutation intro-
duced into the bel-l gene Ieads to an inactivation of the 
respective protein, which is consistent with results for the 
functional dissection of bel-l reported recently (14, 38). 
Stability of mutants and identification of ac:cessory viral 
proteins. The aforementioned experiments did not rule out 
the possibility of early revertions of the point mutants. 
Therefore, lysates of BHK cells infected with plasmid-
derived stock viruses were harvested when the CPE was 
maximal and tested with antibodies against HFV gag, bel-l, 
and bel-2 by Western blot (immunoblot). 
As shown in Fig. 2A, all analyzed viruses expressed the 
gag precursor molecule with an apparent molecular weight of 
70,000 to 74,000 and the 32K major capsid protein (2). With 
bel-l antiserum, two bands became visible (Fig. 2B): a band 
at 36,000 representing the authentic bel-l protein (14, 21) and 
a band at 60,000 in the lanes of wild-type and pHSRV- and 
M8-derived viruses. Since a protein with an identical molec-
ular w~ight was also stained with the bel-2 antiserum (Fig. 
2C), th1s experiment corroborates the previous finding of a 
bel-1/bel-2 fusion protein (bet) (14, 21, 23). In the lanes of 
Fig. 2B corresponding to lysates of M2- to M5-infected cells, 
four novel bel-l reactive proteins of higher electrophoretic 
mobility, which ideally match the truncations of the bet ORF 
introduced into these mutants, became visible (see above 
and Fig. lC). In particular, proteins with approXimate mo-
lecular weights of 14,000, 18,000, 28,000, and 56,000 were 
observed in the lanes with lysates from M4-, M5-, M2-, and 
M3-infected cells, respectively. These proteins therefore 
represent truncated bet proteins. With the exception of the 
56K protein of M3, which has a small in-frame bet ORF 
deletion (see above), the other truncated proteins were not 
stained with our bet reactive antiserum (Fig. 2C) because the 
serum was generated against the carbox:y-terminal bel-2 
ORF. 
Of particular interest were M3, M4, and M8. With mutant 
M3 we did not observe any difference in staining with bel-l 
?r bel-2 antiserum compared with wild-type- and pHSRV-
mfected cells, except for the truncated bet protein. Thus, we 
could not observe the disappearance of the postulated beo 
protein w~th a molecular weight of approximately 27,000 (23) 
m M3. W1th mutant M4, the bel-2 antiserum did not stain the 
postulated 43K bel-2 protein, although this mutant leaves the 
bel-2 coding sequence intact and the truncated bet is pro-
cessed normally. With mutant M8, again no difference 
appeared compared with wild-type- or pHSRV-infected cells 
whe~ stained with bel-l antiserum, as would be expected for 
the d1sappearance ofthe postulated bel-1/bel-3 fusion protein 
with a molecular weight of approximately 23,000 (23) in M8. 
However, there were several minor, bel-land bel-2 antiser-
um-reactive bands detectable in the lanes of those viruses 
which gave rise to full-length bet protein. In conclusion, the 
Western blot results demonstrated that the point mutations 
~troduced into M4 and M5 were stable upon replication in 
vttro. 
. When pHSRV-infected cells were analyzed by indirect 
IDlmunoftuorescence assay with bel-1-reactive antiserum, 
we observed cells displaying nuclear ftuorescence in addition 
to cells with predominant cytoplasmatic ftuorescence as 
described earlier (21), while the bel-2 antiserum gave rise to 
only a cytoplasmic ftuorescence (Fig. 3B to D). A strong 
nuclear ftuorescence was also seen with M4-infected cells 
reacted with bel-l antiserum; but no staining was observed 
in these cells with the bel-2 reactive serum, again indicating 
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FIG. 2. Western blot analysis with anti-gag (A)-, -bel-l (B}-, and -bel-2 (C)-directed serum in lysates from ceUs infected with wild-type 
virus or pHSRV, M2, M3, M4, M5, or M8 transfection-derived virus. (A) 1be gag precursor molecules (pr70n+"'B) and the major capsid 
protein p32B'W were detected in alllysates, except that from tbe uninfected BHK control ceUs. (B) bel-l antiserum detected the 36K bel-l 
protein in alllysates and the 60K bet protein in lysates from wild-type-, pHSRV-, and M8-infected ceUs.ln M4-, MS-, M2-, and M3-infected 
cells, the bet proteins have reduced molecular weights of approximately 14,000, 17,000, 29,000, and 56,000, respectively, which are in 
accordance with tbe sizes of the mutations introduced into the bet ORF in these mutants (Fig. 1}, and demoostrate the stability of the point 
mutants M4 and MS. (C) Lysates were reacted with antiserum directed against the carboxy-terminal bet protein. FuU-Iength bet proteinwas 
detected in lanes witb wild-type virus, pHSRV, and M8. The truncated 56K bet proteinwas stained in tbe lane of M3, wbich has an intemal 
deletion, and no proteins were detected in the lanes of mutants with early truncations in the bel-2 reading frame. MW, molecular weights (in 
thousands}, indicated on the left. 
that the postulated bel-2 and beo proteins are beyond the 
Ievel of detection by the immunological methods applied in 
this study and further demonstrating that bet was destroyed 
in this mutant (Fig. 3F). 
No evidence for a posttranscriptional regulatory protein. 
Since our results indicated that the transactivator bel-l is the 
only regulatory HFV protein required for replication in 
vitro, we investigated the possibility that bel-l is a bifunc-
tional protein, regulating HFV gene expression on a tran-
scriptional and posttranscriptionallevel. To accomplish this, 
we cloned the HFV genome behind the SV 40 early enhanc-
er-promoter and introduced three mutants in the bel region, 
destroying either bel-l alone or several of the postulated 
bel-region-derived proteins (Fig. 10). Lysates were pre-
pared from transfected BHK cells and probed with the gag 
antibody in a Western blot. The expression of gag, as weil as 
pol and env proteins of other complex retroviruses, essen-
tially requires the presence of cis-acting RNA elements and 
trans-acting regulatory proteins (6, 37). As can be seen from 
Fig. 4A, all SV 40 promoter-driven constructs are able to 
express HFV gag. Similar results were obtained when ly-
sates were reacted with anti-pol-directed antiborlies (25) 
(data not shown). These results indicate that HFV does not 
possess a posttranscriptionally acting regulatory protein for 
the expression of its structural genes. 
Staining of the blots with bel-l antiserum revealed the 
presence of bel-l in pHSRV, pSHFV-1, and pSHFV-2, the 
presence of full-length bet in pHSRV, pSHFV-1, and 
pSHFV-4, and the presence of a truncated bet in pSHFV-2-
transfected cells as expected (Fig. 4B). Reaction with bel-2 
antibody revealed authentic bet protein in the Ianes with 
lysates from pHSRV-, pSHFV-1-, and pSHFV-4-transfected 
cells. Consistent with the results presented above for mutant 
M4, no bel-2 proteinwas observed in pSHFV-4-transfected 
cells. However, there appeared several bel-l and bel-2 
reactive proteins smaller than bet in lysates of pHSRV- and 
pSHFV-1-transfected cells, some of which bad sizes of the 
calculated molecular weights of bel-2 and beo (24), but they 
may also represent degradation products of bet. 
DISCUSSION 
In this study we performed for the first time a detailed 
analysis of the requirement of HFV accessory reading 
frames for in vitro viral replication. Using point and deletion 
mutations in the regulatory region of an infectious molecular 
clone, we could show that bel-l is the only accessory HFV 
protein necessary for viral replication in vitro. While bel-l is 
a requisite for virus replication, our results indicate that it is 
only a transactivator of transcription. By assuming that no 
further yet-unidentified regulatory protein is expressed by 
HFV, our findings cantrast with those for other complex 
retroviruses which possess two regulatory proteins, one 
acting on the transcriptional Ievel and one acting on the 
posttranscriptionallevel, to express their structural genes (5, 
6, 28). At least in human immunodeficiency virus the neces-
sity for the rev protein has been attributed to inhibitory 
sequences in the gag-pol and env mRNAs, which negatively 
inftuence the efficiency of the cytoplasmic transport and the 
translation of these mRNAs, unless they are complexed with 
rev via the rev response element (5, 6, 28, 36). The apparent 
Iack of such a regulatory mechanism inHFV and probably in 
all foamy viruses may indicate that inhibitory sequences are 
not present in foamy virus mRNAs. 
With respect to the bei-region-derived proteins (bel-l, 
bel-2, bel-3, bet, bes, and beo), our study shows some 
discrepancies from the earlier reports (21, 23). The postu-
lated bel-2 and beo proteins and the bel-1/bel-3 fusion protein 
could not be identified with any of our mutants. Our failure 
to demoostrate these proteins might be due to a Iack in 
sensitivity of the Western blot and the immunoftuorescence 
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FIG. 3. lndirect immunoftuorescence of primuy human fibroblasts infected with pHSRV (A to D)· and M4 (E and F)-derived virus. Tbe 
first antibody was from preimmune serum (A), directed against the bel-l protein (B, C, and E) or against tbe bel-2 protein (D and F). Panels 
A and F bave been overexposed. 
compared with the polymerase chain reaction (23). Further-
more, we cannot exclude that these proteins are expressed 
only in certain narrow phases of the viral replication cycle, 
which were missed when we harvested the Iysates for 
Western blot analysis. Further analysis, for example, kinetic 
sturlies with our mutants, may resolve this point. How-
ever, as specified above, one of the two proteins, beo or the 
bel-1/bel-3 fusion protein, cannot be generatedas previously 
published 
(23). 
Two of the bel-region-derived proteins, bel-l and bet (a 
fusion protein of bel-l and bel-2 ORF sequences) were 
identified by Western blot and immunofluorescence analysis. 
Consistent with earlier reports, bel-l was shown tobe a 36K 
nuclear protein, while bet behaved like a cytoplasmic protein 
with an approximate molecular weight of 60,000, slightly 
Iarger than reported previously (21). The Western blot 
experiments indicate that bet, although dispensable for virus 
replication in vitro, is an abundant. viral protein. In a 
previous study, a 60K intracellular proteinwas found tobe 
among the immunodominant virus proteins when lysates of 
HFV -infected cells were reacted with foamy virus-positive 
sera of human and primate origins (24), whicb may indicate 
that bet is also expressed in the infected host. In lentiviruses 
some accessory virus proteins, in particular, nef, have Iittle, 
if any, inßuence on virus replication in vitro, and their 
functions remain obscure (13, 18). However, it was shown 
by experiments with animals that nef as weil as the vpr gene 
product is essential for efficient replication in vivo and 
induction of disease (17, 19). lt is therefore tempting to 
speculate that bet promotes a similar effect, at least regard-
VoL. 67, 1993 
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FIG. 4. Western blot analysis of lysates of BHK-21 cells transiently transfected with the infectious full-length plasmid pHSRV or with 
constructs in which geneexpressionwas directed by the SV40 promoter and which bear mutations in the bel genes (for details, see Fig. 1). 
Blots were developed with antisera directed against gag (A), bel-l (B), and bel-2 (C). The detection of gag antigen in cells transfected with 
mutants irrespective of whether they encode any of the bel proteins is indicative of the Iack of a posttranscriptionally acting regulatory protein 
of HFV. MW, molecular weight (in thousands), indicated on the left. 
ing the virus replication characteristics, in the foamy virus-
infected host. 
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